The University of California, San Diego is a public land-grant research university in San Diego, California.

During the past decade, UC San Diego conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 22 clinical trials were completed, i.e. on average, 36.1% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 12 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UC San Diego" #1 sponsor was "University of California, San Diego" with 30 trials, followed by "Pfizer" with 4 trials sponsored, "Actelion" with 3 trials sponsored, "Biogen" with 2 trials sponsored and "Dendreon" with 2 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UC San Diego" #1 collaborator was "Medical University of South Carolina" with 5 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 3 trials as a collaborator, "University of Cincinnati" with 3 trials as a collaborator and "AICR Matching Grant Program (California Walnut Commission and AICR)" with 1 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "UC San Diego" are "Pulmonary Arterial Hypertension" (4 trials), "Sedentary Lifestyle" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Physical Activity" (3 trials) and "Pulmonary Hypertension" (3 trials). Many other conditions were trialed in "UC San Diego" in a lesser frequency.

Most popular intervention types in "UC San Diego" are "Drug" (33 trials), "Other" (13 trials), "Behavioral" (12 trials), "Biological" (11 trials) and "Device" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Nivolumab" (3 trials), "Control" (2 trials), "ITIS diet" (2 trials) and "Macitentan" (2 trials). Other intervention names were less common.

The vast majority of trials in "UC San Diego" are 70 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 31 active trials in "UC San Diego". 1 are not yet recruiting, 23 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 40 completed trials in UC San Diego, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in UC San Diego, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 28 trials that are defined as “Not Applicable".